Antimicrobial activity of solithromycin against clinical isolates of Legionella pneumophila serogroup 1. - Wikidata - awgldk - TriplyDB

Antimicrobial activity of solithromycin against clinical isolates of Legionella pneumophila serogroup 1.

Antimicrobial activity of solithromycin against clinical isolates of Legionella pneumophila serogroup 1.

http://www.wikidata.org/entity/Q39054852

about

A New, Potent, and Placenta-Permeable Macrolide Antibiotic, Solithromycin, for the Prevention and Treatment of Bacterial Infections in Pregnancy Legionella pneumophila: The Paradox of a Highly Sensitive Opportunistic Waterborne Pathogen Able to Persist in the Environment Current and emerging Legionella diagnostics for laboratory and outbreak investigations.Ecological Effect of Solithromycin on Normal Human Oropharyngeal and Intestinal Microbiota.The role of solithromycin in the management of bacterial community-acquired pneumonia.Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.Solithromycin for the treatment of community-acquired bacterial pneumonia.Results from the Solithromycin International Surveillance Program (2014).Macrolide resistance in Legionella pneumophila: the role of LpeAB efflux pump.Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy.Antibiotic susceptibility of clinical Legionella pneumophila serogroup 1 strains isolated in Germany.

P2860

Q26749565-12495CA5-4C38-4DBD-B20C-3BD08B924281 Q27023197-02786048-E0EE-4450-B7C3-12399525117F Q34826656-BCA09C2A-88D7-4564-86BF-1433968C6D49 Q37023237-D4D3D831-A068-464C-9FC6-EE0229BD771B Q38723961-C11E397B-A74A-4A02-95B6-CA673A5BFFF9 Q39026738-29CB5B96-727E-4414-B9AF-6D5F9E986399 Q39278428-18DEDD0B-1F3A-4E5F-8DB6-BD749CA18AD8 Q39863979-F9F929C9-2FF2-4D0C-9CD5-B5454F93F24E Q40352718-E4605B54-11C4-49C3-900F-CE02A20A98F7 Q47119741-F440CCFD-AE85-45D7-8D23-626438B37597 Q50026523-91A0A791-08E3-41F3-9B06-06A305736779

P2860

Antimicrobial activity of solithromycin against clinical isolates of Legionella pneumophila serogroup 1.

http://www.wikidata.org/entity/Q39054852

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Antimicrobial activity of soli ...... nella pneumophila serogroup 1.

@en

Antimicrobial activity of soli ...... nella pneumophila serogroup 1.

@nl

type

label

Antimicrobial activity of soli ...... nella pneumophila serogroup 1.

@en

Antimicrobial activity of soli ...... nella pneumophila serogroup 1.

@nl

prefLabel

Antimicrobial activity of soli ...... nella pneumophila serogroup 1.

@en

Antimicrobial activity of soli ...... nella pneumophila serogroup 1.

@nl

P1433

Q39054852-EB775F02-47A9-42AB-90AE-8E93D2DACF2F

P1476

Q39054852-2D365B56-3990-4189-B4CC-C3168A91BF0B

P2093

Q39054852-10CB16E8-BD46-44F0-8EDC-76ED26F1435B

Q39054852-A7D93B4E-D876-4CFE-9775-65A1EA290362

Q39054852-C5699C97-18DF-4018-9D09-C90E9BF921EB

P2860

Q39054852-0930A1DB-3FD5-4966-8D21-EA3BF0C0D585

Q39054852-12030416-4A01-4E81-9806-A12F694CAB86

Q39054852-193594EC-25C1-4B7E-A9AF-F732AB5721E4

Q39054852-244B1BED-491B-44C3-897A-17DFD8C50CDD

Q39054852-26831894-BDB5-4FD0-8846-E74CC47C5EE6

Q39054852-2825CFE3-0A9A-4CA4-86CB-276B3ECDC34A

Q39054852-362B55DF-738E-45C3-9B20-AC48D1296004

Q39054852-3A0A8AF3-2C12-46DE-9EE0-DB89D1CED073

Q39054852-40866D67-EB2E-4328-BBBC-1045B7587CF4

Q39054852-4D4B9165-1EF5-40D1-8357-8257AB265DE0

P304

Q39054852-E9EE53B0-4A3B-4E50-AAB3-C963DAFDD25B

P31

Q39054852-D0797735-4754-4665-B487-17F16121B486

P356

Q39054852-3E5946E6-4BD2-4CBF-9482-8B3105E48D59

P407

Q39054852-B1C8850C-1928-479C-A3CC-083FFFF2B804

P433

Q39054852-13204D9D-5BD9-4660-B12C-96017622B017

P478

Q39054852-CBAE9D0A-DD0F-43EA-981D-2AF5FF399CE0

P50

Q39054852-4655C0AD-AA9E-4F0C-A334-25788586EC0F

P577

Q39054852-F2826BB8-96EA-4BCF-80DF-8F6579D33BE0

P5875

Q39054852-7EF3A1AE-6A54-4667-A4F9-F5D6F76D23AD

P698

Q39054852-ED955BAB-7476-41AF-A90A-F057FD7F8B65

P932

Q39054852-456D7DA5-2599-4753-A044-D2317B4B29AB

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Antimicrobial activity of soli ...... nella pneumophila serogroup 1.

@en

P2093

Cyril Guyard

http://www.w3.org/2001/XMLSchema#string

Julia Mallegol

http://www.w3.org/2001/XMLSchema#string

Prabhavathi Fernandes

http://www.w3.org/2001/XMLSchema#string

P2860

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis

Temperature-regulated formation of mycelial mat-like biofilms by Legionella pneumophila.

Mechanisms of Legionella pneumophila-induced interleukin-8 expression in human lung epithelial cells.

Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method.

Legionella and Legionnaires' disease: 25 years of investigation.

Erythromycin-resistant Neisseria gonorrhoeae and oral commensal Neisseria spp. carry known rRNA methylase genes

CEM-101 activity against Gram-positive organisms.

Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates.

Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae.

P304

909-915

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01639-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Roberto G.Melano

P577

2013-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258923298

http://www.w3.org/2001/XMLSchema#string

P698

24277019

http://www.w3.org/2001/XMLSchema#string

P932

3910839

http://www.w3.org/2001/XMLSchema#string